University at Buffalo, New York, USA
Professor of Neurology, Psychiatry and Psychology Jacobs Neurological Institute, SUNY Buffalo School of Medicine Buffalo General Hospital Buffalo, New York
Ralph Benedict is Professor of Neurology at the SUNY Buffalo School of Medicine. He completed his doctorate at the Arizona State University in 1990, and his postdoctoral residency in neuropsychology at the Johns Hopkins University School of Medicine. Dr. Benedict holds an ABCN diploma, directs a postdoctoral residency program at SUNY Buffalo, and has served on the program committee for INS and the board of directors of the Association for Post-Doctoral Programs in Clinical Neuropsychology since 2001. He has published over 100 journal articles, many focusing on neuropsychological and psychiatric aspects of MS. Dr. Benedict has received grant support from NIH, National MS Society and industry. Most recently his research has focused on neuropsychology, neuroimaging, and multiple sclerosis. He has chaired or served on several task forces for the American Academy of Neurology, Consortium of MS Centers, and National MS Society, and he serves on several grant review or editorial boards. He has conducted a number of studies on the optimal measurement of cognition for MS clinical trails. Dr. Benedict is well known as an author of two widely used memory tests, the Brief Visuospatial Memory Test – Revised and Hopkins Verbal Learning Test – Revised, as well as the Minimal Assessment of Cognitive Function in MS (MACFIMS).
Kessler Foundation, USA
John DeLuca, Ph.D. is the Senior Vice President for Research at Kessler Foundation, a Professor in the Departments of Physical Medicine & Rehabilitation (PM&R) and Neurology and Neuroscience at Rutgers New Jersey Medical School and a licensed psychologist in the States of New Jersey and New York. Prof DeLuca devotes 100% of his time to research and training. He is currently studying disorders of memory and information processing.
Prof DeLuca has published over 250 articles, books and chapters. He is on the editorial board of several journals and serves as the editor for special issues of the journal NeuroRehabilitation on Multiple Sclerosis and for the journal Applied Neuropsychology on chronic fatigue syndrome.
Prof DeLuca serves on numerous committees for both national and international societies associated with Neuropsychology.
University of Bordeaux, France
Dr Bruno Brochet is professor of Neurology at Université Bordeaux-Segalen, France, and Head of the department of Neurology, Centre Hospitalier-Universitaire of Bordeaux, France.
He was trained in medicine at the Faculté de medicine X Bichat (Université Paris-7). After an internship in Bordeaux, he was graduated in Neurology and in Physical medicine. He is an MS specialist and he created the MS Clinic of Bordeaux. He is past president of the “Club Francophone de la Sclérose en Plaques” and member of the scientific and medical advisory board of ARSEP (Association Française contre la Sclérose en plaques) and the Scientific and Medical Advisory Board of LSEP (Ligue Française contre la Sclérose en plaques) for many years. He is member of INSERM U 862 laboratory in which he is the leader of the clinical research group on MS, cognition and imagery. He published mote than 100 papers in peer-reviewed journals.
University of Dusseldorf, Germany
(Previously President 2012-6)
Prof. Penner is a cognitive psychologist and neuroscientist. She studied in Germany at the Universities of Bonn and Berlin and received her diploma in Psychology at the Free University of Berlin. She successfully completed her PhD at the Neuroradiology Department of the University Hospital Basel on the topic „cognitive and functional changes in patients with multiple sclerosis”. From 2003 to 2009 Prof. Penner worked as senior scientist at the Department of Cognitive Psychology and Methodology where she was scientifically engaged in cognition, fatigue and cognitive rehabilitation in MS. In 2009 she received her postdoctoral lecture qualification. From 2009 to April 2015 she worked as senior scientist and lecturer at the University of Basel and in addition in private praxis at the Neurozentrum in Zürich with a focus on neuropsychological assessments in patients with neuroinflammatory and neurodegenerative diseases. In May 2015 Prof. Penner moved to the University of Düsseldorf and founded the COGITO Center for Applied Neurocognition and Neuropsychological Research.
Prof. Penner is a nationally and internationally recognized expert in the field of cognition and fatigue in MS. She developed the fatigue scale for motor and cognitive functions (FSMC), published numerous scientific articles and book chapters and is member of several professional and scientific societies. Her clinical and scientific focus is concentrated on cognitive processes and brain plasticity in neurodegenerative and inflammatory diseases of the human brain. From 2013 to 2015 she was the President of the International MS Cognition Society (IMSCOGS).
University of Florence, Italy
Professor Maria Pia Amato obtained her medical degree at the University of Florence (Italy) in 1983 and became a Board Certified Neurologist in 1987.
She received a specific training in clinical neuroepidemiology as a Research Fellow at the Johns Hopkins University, Baltimore (USA) and at the Erasmus University, Rotterdam (The Netherlands).
She is Associate Professor of Neurology and responsible for the MS Unit at the Department of Neurology, University of Florence, co-chair of the MS Research Group of the Italian Neurological Society and Italian Delegate for MS at the European Federation of Neurological Societies.
She is actively involved in research on MS, at both the national and international level, having published more than 100 papers in peer-reviewed journals. Her specific research focus deals with neuropsychology, clinical epidemiology and therapeutic trials in MS. Among the most relevant contributions in the field of MS-related cognitive disorders are long-term, longitudinal studies on the natural history of cognitive dysfunction, studies on cognitive functioning and relevant MRI correlates in the “benign” phenotype of MS and, more recently, the longitudinal study on cognitive and psychosocial issues in pediatric MS.
Karolinska Institute, Sweden
Sten Fredrikson is Professor of Neurology at the Department of Clinical Neuroscience at the Karolinska Institute in Stockholm, Sweden.
Professor Fredrikson’s research activities in the field of multiple sclerosis were initially focused mainly on immunological studies, including investigations of the cerebrospinal fluid.
Over the recent 25 years, his research activities have also included several other aspects of the disease. He is author of more than 160 published original articles published in peer-reviewed journals, indexed in PubMed, and he is also author of many other review articles and book chapters. Professor Fredrikson is a member of several national and international neurological boards, including chairman of the Educational and Examination Committee of the Swedish Neurological Society and Swedish delegate of the EFNS, European Board of Neurology and MSIF International Medical and Scientific Board.
VU University Medical Center Amsterdam, Netherlands
For decades, multiple sclerosis was regarded as a ‘typical white matter disease’. Geurts’, however, has shown that the grey matter is severely affected as well, and the clinical impact of grey matter damage in MS is often greater than that of white matter damage. Especially cognitive decline, socially and psychologically highly incapacitating to patients, cannot be explained by white matter damage alone. Hisinitial work, elucidating the histopathological characteristics of grey matter damage, the development of new neuroimaging tools to visualize grey matter lesions and the investigation of their clinical relevance, has been importantly expanded by his team in recent years. They investigated specific brain structures important to cognition, such as the thalamus and the hippocampus, and found that these structures are abnormally active and differentially connected within the entire brain network, already in early disease phases. They subsequently set up a unique cohort of stringently selected cognitively impaired MS patients, performed extensive neuropsychological testing, acquired multimodal neuroimaging, and developed our network analysis skills. They found that MS cognitive impairment can be partly compensated for by a temporary reorganization of brain function, a finding that sparked our interest in cognitive rehabilitation. If the peak of functional reorganization can be therapeutically shifted in time, MS patients could perhaps be safeguarded from cognitive decline, potentially for many years. With their comprehensive approach, spanning molecule to mind, they are currently one of the leading teams in the field worldwide. They are currently setting up a Center for Cognitive Rehabilitation that will provide specialist care targeted to the individual patient and accompanied by forefront translational research. Geurts is also working to translate their findings concerning brain network degeneration between neurological diseases (Alzheimer’s, Parkinson’s, neuro-oncology).
University of Dusseldorf, Germany
Undergraduate education at the medical schools of the Universities of Duesseldorf, Glasgow, Oxford, Boston (Harvard), Baltimore (Johns Hopkins), London (Institute of Neurology, Queen Square).
Professor Hartung is member of a large number of international and national societies, serving on executive boards (e.g. President ECTRIMS; European Neurological Society; European Charcot Foundation; Guillain Barre Syndrome Foundation International; International Society for Neuroimmunology; International Federation of Multiple Sclerosis Societies; German and NRW MS Societies:WHO Advisory Board on MS), on the edidtorial board of a number of international journals. He has authored or co-authored more than 400 articles in peer reviewd journals, written more than 80 book chapters and edited 7 books on neurology, neuroimmunology, peripheral nerve diseases and multiple sclerosis. He is a corresponding Member of the American Neurological Association and a Clinical Fellow of the American Academy of Neurology. He is also Fellow of the American Heart Association (Stroke Council).His major clinical and research interests beyond general neurology are in the field of multiple sclerosis, clinical and experimental neuroimmunology, peripheral neuropathies incl Guillain-Barre Syndrome and CIDP, myopathies. He has received several prizes in recognition of his scientific work.
Since 2001 Professor Hans-Peter Hartung holds the Chair of Neurology at Heinrich-Heine University Duesseldorf and is chairman of the Department of Neurology.
Stony Brook University, New York, USA
Steering Committee Chair
Dr. Lauren Krupp received her medical degree from the Albert Einstein College of Medicine, completed her Neurology Residency at Albert Einstein and Montefiore Medical Center, and then completed additional fellowship training at Neuroimmunology/Multiple Sclerosis Branch of the National Institutes of Health.
Dr Krupp is Professor of Neurology and Psychology at Stony Brook University Medical Center and specializes in multiple sclerosis. She is the co-director of the adult MS Comprehensive Care Center at Stony Brook and is the founder and director of the National Pediatric Multiple Sclerosis Center at Stony Brook, having pioneered the first Center in the United States to treat children and adolescents with MS. She received her medical degree from the Albert Einstein College of Medicine and interned at the New York College of Medicine in Westchester, NY. She was resident and chief resident of neurology at Albert Einstein College of Medicine and Montefiore Medical Center and then completed fellowship training at the Neuro-immunology/Multiple Sclerosis Branch of the National Institutes of Health. She is a Fellow of the American Academy of Neurology, founding chair and member of the International Pediatric MS Study Group, and initial chair and current member of the National Network of Pediatric MS Centers of Excellence.
Her clinical research program addresses clinical challenges affecting adults as well as children with MS and focuses on better defining and treating fatigue, mood disturbance, and cognitive dysfunction in MS. She has published more than 100 original articles or chapters and is an internationally acknowledged authority on symptomatic management in multiple sclerosis.
Royal Holloway, University of London, UK
(Previously Secretary 2012-7)
Professor of Neuropsychology and Director of Health and Medicine, Royal Holloway, University of London, UK
Dawn Langdon completed her training as a clinical psychologist at Oxford University and the Institute of Psychiatry, London. She worked as a clinical neuropsychologist at the National Hospital, Queen Square, London for sixteen years, obtaining a PhD on reasoning in organic brain syndromes and registration as both a neuropsychologist and a health psychologist.
She is now a Professor of Neuropsychology at Royal Holloway, University of London. She is neuropsychology lead on a number of multinational trials. Her research work centres on psychological aspects of MS and current projects include the efficacy of medication in protecting cognition, cognitive rehabilitation, cognitive profiles in CIS and early MS and cognition in the later stages of MS, including its relation to early disease status, and measuring and understanding motor planning. She is developing a protocol to optimise communication of drug information to people with MS (BRIMMS: Benefits and Risks of Medication in MS). She is co-chair of both the BICAMS initiative (www.BICAMS.net) and MS in the 21st Century.
She is a frequent contributor to international scientific meetings and committees and is a Trustee of the UK MS Trust, with whom she has authored the MS cognition website www.stayingsmart.org.uk.
Charité Universitätsmedizin Berlin, Germany
Friedemann Paul is professor of clinical neuroimmunology at Charité Universitätsmedizin Berlin, Berlin, Germany. He is head of the neuroimmunology outpatient clinic at the Experimental and Clinical Research Center, a joint translational research facility run by Charité Universitätsmedizin Berlin and Max Delbrueck Center for Molecular Medicine. He co-chairs Charité’s Clinical and Experimental Multiple Sclerosis Research Center. His main research areas are novel imaging techniques in autoimmune disorders of the CNS (optical coherence tomography, advanced MRI including ultrahigh field MRI), the visual system in neuroimmunological disorders and fatigue and cognition in MS and related conditions.